# A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment

> **NCT02448628** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 33 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** CS-3150

## Key facts

- **NCT ID:** NCT02448628
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02448628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02448628, "A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02448628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*